Eneanya, Nwamaka D.

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

Delgado, C., Baweja, M., Crews, D. C., Eneanya, N. D., Gadegbeku, C. A., Inker, L. A., Mendu, M. L., Miller, W. G., Moxey-Mims, M. M., Roberts, G. V., et al. (2022) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesClinical Laboratory Practices and Quality Control

Cited by 783

Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic.

Eberly, L. A., Kallan, M. J., Julien, H. M., Haynes, N., Khatana, S. A. M., Nathan, A. S., Snider, C., Chokshi, N. P., Eneanya, N. D., Takvorian, S. U., et al. (2020) · JAMA Network Open

Telemedicine and Telehealth ImplementationCOVID-19 and healthcare impacts

Cited by 740

Reconsidering the Consequences of Using Race to Estimate Kidney Function

Eneanya, N. D., Yang, W., & Reese, P. P. (2019) · JAMA

Chronic Kidney Disease and DiabetesRace, Genetics, and Society

Cited by 385

Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US

Eberly, L. A., Yang, L., Eneanya, N. D., Essien, U., Julien, H., Nathan, A. S., Khatana, S. A. M., Dayoub, E. J., Fanaroff, A. C., Giri, J., et al. (2021) · JAMA Network Open

Diabetes Treatment and ManagementHealth disparities and outcomes

Cited by 350

Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US

Eberly, L. A., Yang, L., Essien, U. R., Eneanya, N. D., Julien, H. M., Luo, J., Nathan, A. S., Khatana, S. A. M., Dayoub, E. J., Fanaroff, A. C., et al. (2021) · JAMA Health Forum

Diabetes Treatment and ManagementHealth disparities and outcomes

Cited by 288

Examining the Potential Impact of Race Multiplier Utilization in Estimated Glomerular Filtration Rate Calculation on African-American Care Outcomes

Ahmed, S., Nutt, C. T., Eneanya, N. D., Reese, P. P., Sivashanker, K., Morse, M., Sequist, T., & Mendu, M. L. (2021) · Journal of General Internal Medicine

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 147

Health inequities and the inappropriate use of race in nephrology

Eneanya, N. D., Boulware, L. E., Tsai, J., Bruce, M. A., Ford, C. L., Harris, C., Morales, L. S., Ryan, M. J., Reese, P. P., Thorpe, R. J., et al. (2022) · Nature Reviews Nephrology

Race, Genetics, and SocietyChronic Kidney Disease and Diabetes

Cited by 140

Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models

Ashana, D. C., Anesi, G. L., Liu, V. X., Escobar, G. J., Chesley, C., Eneanya, N. D., Weissman, G. E., Miller, W. D., Harhay, M. O., & Halpern, S. D. (2021) · American Journal of Respiratory and Critical Care Medicine

Sepsis Diagnosis and TreatmentEmergency and Acute Care Studies

Cited by 98